Skip to main content

Advertisement

Log in

Does spouse participation influence quality of life reporting in patients with Parkinson’s disease?

  • Brief Communication
  • Published:
Quality of Life Research Aims and scope Submit manuscript

Abstract

Purpose

To investigate whether patient–spouse co-reporting (patient reporting with assistance from their spouse) results in the same ratings of health-related quality of life (HRQoL) as patient ratings without co-reporting, and to assess whether mutuality of the marital relationship is a determinant of co-reported ratings. Patients are the best source of HRQoL; however, co-reporting is common in clinical settings, but has not been compared to independent patient reporting of HRQoL.

Methods

Fifty-nine Parkinson’s disease (PD) patient–spouse pairs completed the Short Form Health Status Survey (SF-12), measuring mental and physical HRQoL. Initially, the patient and spouse completed the SF-12 independently (about the patient). Then, patient–spouse pairs completed the SF-12 together assessing the patient’s HRQoL. Patients and spouses independently completed the Mutuality Scale rating the intimacy of their relationship.

Results

Patients rated physical HRQoL higher (M = 46.6) than spouses alone (M = 43.4, p < 0.01) and co-reporting (M = 44.8, p < 0.05). Co-reporting rated physical HRQoL in between that of patients and spouses, (p < 0.05). Spouses who reported greater mutuality showed greater concordance with the patient regarding the patient’s mental HRQoL (B = −0.43, p < 0.05).

Conclusion

Consistency of the mode of completion of HRQoL instruments is important since co-reporting may alter HRQoL ratings in PD and lead to inaccurate conclusions. Mutuality is a mediator of mental HRQoL.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Martinez-Martin, P. (1998). An introduction to the concept of “Quality of Life in Parkinson’s disease.” Journal of Neurology, 245(Suppl 1), S2–S6.

  2. Martinez-Martin, P., & Kurtis, M. (2012). Health-related quality of life as an outcome variable in Parkinson’s disease. Therapeutic Advances in Neurological Disorders, 5, 105–117.

    Article  PubMed Central  PubMed  Google Scholar 

  3. Martinez-Martin, P. (2013). Instruments for holistic assessment of Parkinson’s disease. Journal of Neural Transmission, 120(4), 559–564.

    Article  PubMed  Google Scholar 

  4. Fleming, A., Cook, K., Nelson, N., & Lai, E. (2005). Proxy reports in Parkinson’s disease: caregiver and patient self-reports of quality of life and physical activity. Movement Disorders, 20, 1462–1468.

    Article  PubMed  Google Scholar 

  5. Martinez-Martin, P., Benito-Leon, J., Alonso, F., Catalan, M., Pondal, M., & Zamarbide, I. (2004). Health-related quality of life evaluation by proxy in Parkinson’s disease: Approach using the PDQ-8 and EuroQol 5D. Movement Disorders, 19, 312–318.

    Article  PubMed  Google Scholar 

  6. Sitek, E., Soltan, W., Wieczorek, D., Robowski, P., & Slawek, J. (2011). Self-awareness of memory function in Parkinson’s disease in relation to mood and symptom severity. Aging and Mental Health, 15(2), 150–156.

    Article  PubMed  Google Scholar 

  7. Andresen, E., Vahle, V., & Lollar, D. (2001). Proxy reliability: health-related quality of life (HRQoL) measures for people with disability. Quality of Life, 10(7), 609–619.

    Article  CAS  Google Scholar 

  8. Tanji, H., Anderson, K., Gruber-Baldini, A., Fishman, P., Reich, S., Weiner, W., et al. (2008). Mutuality of the marital relationship in Parkinson’s disease. Movement Disorders, 23, 1843–1849.

    Article  PubMed  Google Scholar 

  9. US Department of Health and Human Services Food and Drug Administration. (2009). Guidance for industry: patient-reported outcome measures: Use in medical product development to support labeling claims. Retrieved from: http://www.fda.gov/downlods/Drugs/Guidances/UCM193282.pdf.

  10. Goetz, C., Tilley, B., Shaftman, S., et al. (2008). Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Movement Disorders, 23, 2129–2170.

    Article  PubMed  Google Scholar 

  11. Magaziner, J., Zimmerman, S., Gruber-Baldini, A., Hebel, J., & Fox, K. (1997). Proxy reporting in five areas of functional status. American Journal of Epidemiology, 146(5), 418–428.

    Article  CAS  PubMed  Google Scholar 

  12. Magaziner, J. (1997). Use of proxies to measure health and functional outcomes in effectiveness research in patients with Alzheimer disease and related disorders. Alzheimer Disease and Associated Disorders, 11(Suppl 6), 168–174.

    PubMed  Google Scholar 

  13. Dalrymple-Alford, J., MacAskill, M., Nakas, C., Livingston, L., Graham, C., Crucian, G., et al. (2010). The MoCA: Well-suited screen for cognitive impairment in Parkinson disease. Neurology, 75, 1717–1725.

    Article  CAS  PubMed  Google Scholar 

  14. Archbold, P., Stewart, B., Greenlick, M., & Harvath, T. (1990). Mutuality and preparedness as predictors of caregiver role strain. Research in Nursing & Health, 13, 375–384.

    Article  CAS  Google Scholar 

  15. Ware, J., Jr, Kosinski, M., & Keller, S. (1996). A 12-item short-form health survey: Construction of scales and preliminary tests of reliability and validity. Medical Care, 34(2), 220–233.

    Article  PubMed  Google Scholar 

  16. Linn, B., Linn, M., & Gurel, L. (1968). Cumulative illness rating scale. Journal of American Geriatrics Society, 16(5), 622–626.

    CAS  Google Scholar 

  17. Fahn, S., & Elton, R. (1987). Unified Parkinson’s disease rating scale. Macmillan health care information, pp. 153–164.

  18. Hoehn, M. W., & Yahr, M. D. (1967). Parkinsonism: onset, progression, and mortality. Neurology, 17, 427–442.

    Article  CAS  PubMed  Google Scholar 

  19. Sneeuw, K., Sprangers, M., & Aaronson, N. (2002). The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease. Journal of Clinical Epidemiology, 55(11), 1130–1143.

    Article  PubMed  Google Scholar 

  20. Duncan, P., Lai, S., Tyler, D., Perera, S., Reker, D., & Studenski, S. (2002). Evaluation of proxy responses to the Stroke Impact Scale. Stroke, 33, 2593–2599.

    Article  PubMed  Google Scholar 

  21. Snow, L., Cook, K., Lin, P., Morgan, R., & Magaziner, J. (2005). Proxies and other external raters: Methodological considerations. Health Services Research, 40(5 Pt 2), 1676–1693.

    Article  PubMed Central  Google Scholar 

  22. Wolff, J., Boyd, C., Gitlin, L., et al. (2012). Going it together: Persistence of older adults’ accompaniment to physician visits by a family companion. Journal of American Geriatrics Society, 60, 106–112.

    Article  Google Scholar 

  23. Wolff, J., & Roter, D. (2011). Family presence in routine medical visits: A meta-analytical review. Social Science and Medicine, 72(6), 823–831.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

Study supported by: The Rosalyn Newman Foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chelsea D. Morrow.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Morrow, C.D., Smentkowski, K., Schwartz, S. et al. Does spouse participation influence quality of life reporting in patients with Parkinson’s disease?. Qual Life Res 24, 245–249 (2015). https://doi.org/10.1007/s11136-014-0744-2

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11136-014-0744-2

Keywords

Navigation